Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shanshan Luo

Showing results (121-130 of 159) with videos related to

Pageof 16
Sort By:
Scientific Reports|March 8, 2017
ZYZ-168 alleviates cardiac fibrosis after myocardial infarction through inhibition of ERK1/2-dependent ROCK1 activationShanshan Luo, Tran Ba Hieu, Fenfen Ma, et al.
International Journal of Cancer|January 12, 2024
Trps1 predicts poor prognosis in advanced high grade serous ovarian carcinomaXiaojiang Wang, Jiandong Sun, Yue Liu, et al.
Journal of Medicinal Chemistry|April 19, 2016
Probing the Anticancer Action of Oridonin with Fluorescent Analogues: Visualizing Subcellular Localization to MitochondriaShengtao Xu, Shanshan Luo, Hong Yao, et al.
Cell Biology and Toxicology|August 2, 2023
Trps1 acts as a regulator of Sf-1 transcription and testosterone synthesis in mouse Leydig cellsJiandong Sun, Xiuli Lian, Chengyu Lv, et al.
Chinese Medicine|February 28, 2024
The combination of Tanshinone IIA and Astragaloside IV attenuates myocardial ischemia-reperfusion injury by inhibiting the STING pathwayPan Zhai, Qianyun Chen, Xunxun Wang, et al.
International Journal of Environmental Research and Public Health|September 9, 2022
Big Five Traits as Predictors of a Healthy Lifestyle during the COVID-19 Pandemic: Results of a Russian Cross-Sectional StudyAlena Zolotareva, Sergei Shchebetenko, Svetlana Belousova, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|May 28, 2020
Cardiovascular disease potentially contributes to the progression and poor prognosis of COVID-19Mingyue Li, Yalan Dong, Haijun Wang, et al.
Clinical Immunology (Orlando, Fla.)|July 14, 2020
Long-term infection of SARS-CoV-2 changed the body's immune statusLan Lin, Shanshan Luo, Renjie Qin, et al.
Diabetes/Metabolism Research and Reviews|April 2, 2020
Diabetes is a risk factor for the progression and prognosis of COVID-19Weina Guo, Mingyue Li, Yalan Dong, et al.
Leukemia|June 30, 2025
SIRT5 inhibition impairs mitochondrial metabolism and enhances venetoclax-induced elimination of acute myeloid leukemia cellsMoran Wang, Ruiqi Zhu, Donald Small, et al.
Pageof 16

Showing results (121-130 of 159) with videos related to

Sort By:
Pageof 16
Scientific Reports|March 8, 2017
ZYZ-168 alleviates cardiac fibrosis after myocardial infarction through inhibition of ERK1/2-dependent ROCK1 activationShanshan Luo, Tran Ba Hieu, Fenfen Ma, et al.
International Journal of Cancer|January 12, 2024
Trps1 predicts poor prognosis in advanced high grade serous ovarian carcinomaXiaojiang Wang, Jiandong Sun, Yue Liu, et al.
Journal of Medicinal Chemistry|April 19, 2016
Probing the Anticancer Action of Oridonin with Fluorescent Analogues: Visualizing Subcellular Localization to MitochondriaShengtao Xu, Shanshan Luo, Hong Yao, et al.
Cell Biology and Toxicology|August 2, 2023
Trps1 acts as a regulator of Sf-1 transcription and testosterone synthesis in mouse Leydig cellsJiandong Sun, Xiuli Lian, Chengyu Lv, et al.
Chinese Medicine|February 28, 2024
The combination of Tanshinone IIA and Astragaloside IV attenuates myocardial ischemia-reperfusion injury by inhibiting the STING pathwayPan Zhai, Qianyun Chen, Xunxun Wang, et al.
International Journal of Environmental Research and Public Health|September 9, 2022
Big Five Traits as Predictors of a Healthy Lifestyle during the COVID-19 Pandemic: Results of a Russian Cross-Sectional StudyAlena Zolotareva, Sergei Shchebetenko, Svetlana Belousova, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|May 28, 2020
Cardiovascular disease potentially contributes to the progression and poor prognosis of COVID-19Mingyue Li, Yalan Dong, Haijun Wang, et al.
Clinical Immunology (Orlando, Fla.)|July 14, 2020
Long-term infection of SARS-CoV-2 changed the body's immune statusLan Lin, Shanshan Luo, Renjie Qin, et al.
Diabetes/Metabolism Research and Reviews|April 2, 2020
Diabetes is a risk factor for the progression and prognosis of COVID-19Weina Guo, Mingyue Li, Yalan Dong, et al.
Leukemia|June 30, 2025
SIRT5 inhibition impairs mitochondrial metabolism and enhances venetoclax-induced elimination of acute myeloid leukemia cellsMoran Wang, Ruiqi Zhu, Donald Small, et al.
Pageof 16